| 000 | 01754nam a2200205Ia 4500 | ||
|---|---|---|---|
| 008 | 250806s9999||||xx |||||||||||||| ||und|| | ||
| 060 |
_aQV 754 _b.D78 2000 |
||
| 245 | 0 |
_aDrug stability : _bprinciples and practices / _cedited by C.T. Rhodes, Jens T. Carstensen. |
|
| 250 | _a3rd ed., rev. and expanded. | ||
| 260 |
_aNew York : _bMarcel Dekker, _c2000 |
||
| 300 |
_aVol.107, vii, 773 p.: _bill. _c26 cm. |
||
| 490 | _aDrugs and the pharmaceutical sciences | ||
| 500 | _aRev. ed. of: Drug stability / Jens T. Carstensen. 2nd ed., rev. and expanded. 1995. | ||
| 504 | _aIncludes bibliographical references (p. 99-100) and index. | ||
| 505 | _aIntroductory overview -- Solution kinetics -- Kinetic pH profiles -- Oxidation in solution -- Catalysis, complexation, and photolysis -- Solid state stability -- Interactions of moisture with solids -- Physical characteristics of solids -- Performulation -- Physical testing -- Development and validation of HPLC stability-indicationg assays -- Stability testing of clinical trial materials -- A rational approach to stability testing and analytical development for NCE, drug substance, and drug products: marketed product stability testing -- Packaging, package evaluation, stability, and shelf-life -- Industrial stability testing in the United States and computerization of stability data -- Stability of polypeptides and proteins -- Regulatory aspects of stability testing in Europe -- Regulatory and scientific aspects of stability testing: present and possible future trends -- Appn.: Guidance for industry: stability testing of drug substances and drug products (draft). | ||
| 650 | _aDrug Stability | ||
| 700 | _aCarstensen, Jens Thur??, | ||
| 700 | _aRhodes, Christopher T., | ||
| 942 |
_bDIMC _cBK |
||
| 999 |
_c27926 _d27926 |
||